drugset / Trial / NCT03623984

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

NCT03623984

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see if the use of 68Gallium- positron emission tomography and computer tomography (PET/CT) scans along with NETSPOT® (Advanced Accelerator Applications USA, Inc.) can better define the localization of Neuroendocrine tumors enhancing the surgical removal of Neuroendocrine tumors (NETs).

Timeline

Start
2019-06-07
Primary completion
2022-06-07
Completion
2023-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-DOTATATE Diagnostic / imaging agent Other